These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8384226

  • 1. Inhibition of cytokine-primed eosinophil chemotaxis by nedocromil sodium.
    Warringa RA, Mengelers HJ, Maikoe T, Bruijnzeel PL, Koenderman L.
    J Allergy Clin Immunol; 1993 Mar; 91(3):802-9. PubMed ID: 8384226
    [Abstract] [Full Text] [Related]

  • 2. Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Warringa RA, Koenderman L, Kok PT, Kreukniet J, Bruijnzeel PL.
    Blood; 1991 Jun 15; 77(12):2694-700. PubMed ID: 1646045
    [Abstract] [Full Text] [Related]

  • 3. Effects of nedocromil sodium on in vitro induced migration, activation, and mediator release from human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet H, Koenderman L.
    J Allergy Clin Immunol; 1993 Jul 15; 92(1 Pt 2):159-64. PubMed ID: 8393021
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr 15; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma.
    Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L.
    J Allergy Clin Immunol; 1993 Jun 15; 91(6):1198-205. PubMed ID: 8509580
    [Abstract] [Full Text] [Related]

  • 6. Modulation of eosinophil chemotaxis by interleukin-5.
    Warringa RA, Schweizer RC, Maikoe T, Kuijper PH, Bruijnzeel PL, Koendermann L.
    Am J Respir Cell Mol Biol; 1992 Dec 15; 7(6):631-6. PubMed ID: 1449809
    [Abstract] [Full Text] [Related]

  • 7. In vivo priming of platelet-activating factor-induced eosinophil chemotaxis in allergic asthmatic individuals.
    Warringa RA, Mengelers HJ, Kuijper PH, Raaijmakers JA, Bruijnzeel PL, Koenderman L.
    Blood; 1992 Apr 01; 79(7):1836-41. PubMed ID: 1558975
    [Abstract] [Full Text] [Related]

  • 8. Concentration-dependent activity of mometasone furoate and dexamethasone on blood eosinophils isolated from atopic children: modulation of Mac-1 expression and chemotaxis.
    Sale R, Sabatini F, Silvestri M, Serpero L, Petecchia L, Rossi GA.
    Int Immunopharmacol; 2004 Dec 15; 4(13):1687-96. PubMed ID: 15454120
    [Abstract] [Full Text] [Related]

  • 9. The effect of nedocromil sodium on human eosinophil activation.
    Moqbel R, Cromwell O, Kay AB.
    Drugs; 1989 Dec 15; 37 Suppl 1():19-22; discussion 69-77. PubMed ID: 2547563
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects.
    Sehmi R, Wardlaw AJ, Cromwell O, Kurihara K, Waltmann P, Kay AB.
    Blood; 1992 Jun 01; 79(11):2952-9. PubMed ID: 1316789
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
    Kurihara K, Wardlaw AJ, Moqbel R, Kay AB.
    J Allergy Clin Immunol; 1989 Jan 01; 83(1):83-90. PubMed ID: 2536413
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
    Bruijnzeel PL, Warringa RA, Kok PT, Hamelink ML, Kreukniet J.
    Drugs; 1989 Jan 01; 37 Suppl 1():9-18; discussion 69-77. PubMed ID: 2547570
    [Abstract] [Full Text] [Related]

  • 13. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4.
    Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L.
    J Invest Dermatol; 1993 Feb 01; 100(2):137-42. PubMed ID: 8429236
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of eosinophil density change and leukotriene C4 generation by nedocromil sodium.
    Sedgwick JB, Bjornsdottir U, Geiger KM, Busse WW.
    J Allergy Clin Immunol; 1992 Aug 01; 90(2):202-9. PubMed ID: 1323588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects.
    Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB.
    Clin Exp Allergy; 1993 Dec 01; 23(12):1027-36. PubMed ID: 10779297
    [Abstract] [Full Text] [Related]

  • 18. Effects of eosinophilotropic cytokines on differentiation of an eosinophil cell line, YY-1.
    Ueno M, Watanabe K, Tsurufuji S, Hirashima M.
    Int Arch Allergy Immunol; 1994 Dec 01; 104 Suppl 1(1):60-2. PubMed ID: 8156008
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of cetirizine on cytokine-enhanced in vitro eosinophil survival.
    Sedgwick JB, Busse WW.
    Ann Allergy Asthma Immunol; 1997 Jun 01; 78(6):581-5. PubMed ID: 9207722
    [Abstract] [Full Text] [Related]

  • 20. Cytokines induce selective granulocyte chemotactic responses.
    Bittleman DB, Erger RA, Casale TB.
    Inflamm Res; 1996 Feb 01; 45(2):89-95. PubMed ID: 8907590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.